Building better drugs faster for the brain.
pitch_v1_importSee something off about this company?
There are few options for the treatment of neurological and neurodegenerative diseases. The market for neurodegenerative diseases is roughly $52B, while the market for neurological diseases is roughly$ 82B. The market for brain cancer, a traditionally tricky cancer to treat and one that is also applicable to our platform, is several billion as well. If you include all neurological disorders, including rare/orphan diseases, the market is $125.3B by 2030.
